Photodynamic Therapy in Cancer: Principles, State of the Art, and Future Directions

Dmitri V. Krysko,Irina V. Balalaeva,Tatiana A. Mishchenko

DOI: https://doi.org/10.3390/pharmaceutics16121564

IF: 6.525

2024-12-07

Pharmaceutics

Abstract:Since its discovery more than 100 years ago, photodynamic therapy (PDT) has become a potent strategy for the treatment of many types of cancer [...]

pharmacology & pharmacy

What problem does this paper attempt to address?

Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors

Mingying Yang,Tao Yang,Chuanbin Mao

DOI: https://doi.org/10.1002/anie.201814098

2019-01-01

Abstract:The viable use of photodynamic therapy (PDT) in cancer therapy has never been fully realized because of its undesirable effects on healthy tissues. Herein we summarize some physicochemical factors that can make PDT a more viable and effective option to provide future oncological patients with better-quality treatment options. These physicochemical factors include light sources, photosensitizer (PS) carriers, microwaves, electric fields, magnetic fields, and ultrasound. This Review is meant to provide current information pertaining to PDT use, including a discussion of in vitro and in vivo studies. Emphasis is placed on the physicochemical factors and their potential benefits in overcoming the difficulty in transitioning PDT into the medical field. Many advanced techniques, such as employing X-rays as a light source, using nanoparticle-loaded stem cells and bacteriophage bio-nanowires as a photosensitizer carrier, as well as integration with immunotherapy, are among the future directions.
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

Demian van Straten,Vida Mashayekhi,Henriette S. de Bruijn,Sabrina Oliveira,Dominic J. Robinson,Henriette de Bruijn,Dominic Robinson

DOI: https://doi.org/10.3390/cancers9020019

2017-02-18

Cancers

Abstract:Photodynamic therapy (PDT) is a clinically approved cancer therapy, based on a photochemical reaction between a light activatable molecule or photosensitizer, light, and molecular oxygen. When these three harmless components are present together, reactive oxygen species are formed. These can directly damage cells and/or vasculature, and induce inflammatory and immune responses. PDT is a two-stage procedure, which starts with photosensitizer administration followed by a locally directed light exposure, with the aim of confined tumor destruction. Since its regulatory approval, over 30 years ago, PDT has been the subject of numerous studies and has proven to be an effective form of cancer therapy. This review provides an overview of the clinical trials conducted over the last 10 years, illustrating how PDT is applied in the clinic today. Furthermore, examples from ongoing clinical trials and the most recent preclinical studies are presented, to show the directions, in which PDT is headed, in the near and distant future. Despite the clinical success reported, PDT is still currently underutilized in the clinic. We also discuss the factors that hamper the exploration of this effective therapy and what should be changed to render it a more effective and more widely available option for patients.

oncology
Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions

José H. Correia,José A. Rodrigues,Sara Pimenta,Tao Dong,Zhaochu Yang

DOI: https://doi.org/10.3390/pharmaceutics13091332

IF: 6.525

2021-08-25

Pharmaceutics

Abstract:Photodynamic therapy (PDT) is a minimally invasive therapeutic modality that has gained great attention in the past years as a new therapy for cancer treatment. PDT uses photosensitizers that, after being excited by light at a specific wavelength, react with the molecular oxygen to create reactive oxygen species in the target tissue, resulting in cell death. Compared to conventional therapeutic modalities, PDT presents greater selectivity against tumor cells, due to the use of photosensitizers that are preferably localized in tumor lesions, and the precise light irradiation of these lesions. This paper presents a review of the principles, mechanisms, photosensitizers, and current applications of PDT. Moreover, the future path on the research of new photosensitizers with enhanced tumor selectivity, featuring the improvement of PDT effectiveness, has also been addressed. Finally, new applications of PDT have been covered.

pharmacology & pharmacy
Photodynamic Therapy: Current Status and Future Directions

Ludmil Benov

DOI: https://doi.org/10.1159/000362416

2015-01-01

Medical Principles and Practice

Abstract:Photodynamic therapy (PDT) is a minimally invasive therapeutic modality used for the management of a variety of cancers and benign diseases. The destruction of unwanted cells and tissues in PDT is achieved by the use of visible or near-infrared radiation to activate a light-absorbing compound (a photosensitizer, PS), which, in the presence of molecular oxygen, leads to the production of singlet oxygen and other reactive oxygen species. These cytotoxic species damage and kill target cells. The development of new PSs with properties optimized for PDT applications is crucial for the improvement of the therapeutic outcome. This review outlines the principles of PDT and discusses the relationship between the structure and physicochemical properties of a PS, its cellular uptake and subcellular localization, and its effect on PDT outcome and efficacy.

medicine, general & internal
The Current Status of Photodynamic Therapy in Cancer Treatment

Wenqi Jiang,Mingkang Liang,Qifang Lei,Guangzhi Li,Song Wu

DOI: https://doi.org/10.3390/cancers15030585

2023-01-19

Cancers

Abstract:Although we have made great strides in treating deadly diseases over the years, cancer therapy still remains a daunting challenge. Among numerous anticancer methods, photodynamic therapy (PDT), a non-invasive therapeutic approach, has attracted much attention. PDT exhibits outstanding performance in cancer therapy, but some unavoidable disadvantages, including limited light penetration depth, poor tumor selectivity, as well as oxygen dependence, largely limit its therapeutic efficiency for solid tumors treatment. Thus, numerous strategies have gone into overcoming these obstacles, such as exploring new photosensitizers with higher photodynamic conversion efficiency, alleviating tumor hypoxia to fuel the generation of reactive oxygen species (ROS), designing tumor-targeted PS, and applying PDT-based combination strategies. In this review, we briefly summarized the PDT related tumor therapeutic approaches, which are mainly characterized by advanced PSs, these PSs have excellent conversion efficiency and additional refreshing features. We also briefly summarize PDT-based combination therapies with excellent therapeutic effects.

oncology
Enhancing Precision in Photodynamic Therapy: Innovations in Light-Driven and Bioorthogonal Activation

Natalia S. Kuzmina,Ekaterina A. Fedotova,Petar Jankovic,Galina P. Gribova,Alexander V. Nyuchev,Alexey Yu. Fedorov,Vasilii F. Otvagin

DOI: https://doi.org/10.3390/pharmaceutics16040479

IF: 6.525

2024-04-01

Pharmaceutics

Abstract:Over the past few decades, photodynamic therapy (PDT) has evolved as a minimally invasive treatment modality offering precise control over cancer and various other diseases. To address inherent challenges associated with PDT, researchers have been exploring two promising avenues: the development of intelligent photosensitizers activated through light-induced energy transfers, charges, or electron transfers, and the disruption of photosensitive bonds. Moreover, there is a growing emphasis on the bioorthogonal delivery or activation of photosensitizers within tumors, enabling targeted deployment and activation of these intelligent photosensitive systems in specific tissues, thus achieving highly precise PDT. This concise review highlights advancements made over the last decade in the realm of light-activated or bioorthogonal photosensitizers, comparing their efficacy and shaping future directions in the advancement of photodynamic therapy.

pharmacology & pharmacy
The Perspective of Photodynamic Therapy in Cancer Management

Fernanda Viana Cabral,Jose Quilez Alburquerque,Harrison James Roberts,Tayyaba Hasan

DOI: https://doi.org/10.3390/ijms25073811

IF: 5.6

2024-03-30

International Journal of Molecular Sciences

Abstract:The persistent failure of standard chemotherapy underscores the urgent need for innovative and targeted approaches in cancer treatment. Photodynamic therapy (PDT) has emerged as a promising photochemistry-based approach to address chemoresistance in cancer regimens. PDT not only induces cell death but also primes surviving cells, enhancing their susceptibility to subsequent therapies. This review explores the principles of PDT and discusses the concept of photodynamic priming (PDP), which augments the effectiveness of treatments like chemotherapy. Furthermore, the integration of nanotechnology for precise drug delivery at the right time and location and PDT optimization are examined. Ultimately, this study highlights the potential and limitations of PDT and PDP in cancer treatment paradigms, offering insights into future clinical applications.

biochemistry & molecular biology,chemistry, multidisciplinary
Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status

Gurcan Gunaydin,M. Emre Gedik,Seylan Ayan

DOI: https://doi.org/10.3389/fchem.2021.686303

IF: 5.5

2021-08-02

Frontiers in Chemistry

Abstract:Photodynamic therapy (PDT) has been used as an anti-tumor treatment method for a long time and photosensitizers (PS) can be used in various types of tumors. Originally, light is an effective tool that has been used in the treatment of diseases for ages. The effects of combination of specific dyes with light illumination was demonstrated at the beginning of 20th century and novel PDT approaches have been developed ever since. Main strategies of current studies are to reduce off-target effects and improve pharmacokinetic properties. Given the high interest and vast literature about the topic, approval of PDT as the first drug/device combination by the FDA should come as no surprise. PDT consists of two stages of treatment, combining light energy with a PS in order to destruct tumor cells after activation by light. In general, PDT has fewer side effects and toxicity than chemotherapy and/or radiotherapy. In addition to the purpose of treatment, several types of PSs can be used for diagnostic purposes for tumors. Such approaches are called photodynamic diagnosis (PDD). In this Review, we provide a general overview of the clinical applications of PDT in cancer, including the diagnostic and therapeutic approaches. Assessment of PDT therapeutic efficacy in the clinic will be discussed, since identifying predictors to determine the response to treatment is crucial. In addition, examples of PDT in various types of tumors will be discussed. Furthermore, combination of PDT with other therapy modalities such as chemotherapy, radiotherapy, surgery and immunotherapy will be emphasized, since such approaches seem to be promising in terms of enhancing effectiveness against tumor. The combination of PDT with other treatments may yield better results than by single treatments. Moreover, the utilization of lower doses in a combination therapy setting may cause less side effects and better results than single therapy. A better understanding of the effectiveness of PDT in a combination setting in the clinic as well as the optimization of such complex multimodal treatments may expand the clinical applications of PDT.

chemistry, multidisciplinary
Recent Studies in Photodynamic Therapy for Cancer Treatment: From Basic Research to Clinical Trials

Tae Eun Kim,Ji-Eun Chang

DOI: https://doi.org/10.3390/pharmaceutics15092257

IF: 6.525

2023-08-31

Pharmaceutics

Abstract:Photodynamic therapy (PDT) is an emerging and less invasive treatment modality for various types of cancer. This review provides an overview of recent trends in PDT research, ranging from basic research to ongoing clinical trials, focusing on different cancer types. Lung cancer, head and neck cancer, non-melanoma skin cancer, prostate cancer, and breast cancer are discussed in this context. In lung cancer, porfimer sodium, chlorin e6, and verteporfin have shown promising results in preclinical studies and clinical trials. For head and neck cancer, PDT has demonstrated effectiveness as an adjuvant treatment after surgery. PDT with temoporfin, redaporfin, photochlor, and IR700 shows potential in early stage larynx cancer and recurrent head and neck carcinoma. Non-melanoma skin cancer has been effectively treated with PDT using methyl aminolevulinate and 5-aminolevulinic acid. In prostate cancer and breast cancer, PDT research is focused on developing targeted photosensitizers to improve tumor-specific uptake and treatment response. In conclusion, PDT continues to evolve as a promising cancer treatment strategy, with ongoing research spanning from fundamental investigations to clinical trials, exploring various photosensitizers and treatment combinations. This review sheds light on the recent advancements in PDT for cancer therapy and highlights its potential for personalized and targeted treatments.

pharmacology & pharmacy
Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer

Scott C. Hester,Maju Kuriakose,Christopher D. Nguyen,Srivalleesha Mallidi

DOI: https://doi.org/10.1111/php.13217

2020-03-01

Photochemistry and Photobiology

Abstract:<p>Photodynamic therapy (PDT) is a phototoxic treatment with high spatial and temporal control and has shown tremendous promise in the management of cancer due to its high efficacy and minimal side effects. PDT efficacy is dictated by a complex relationship between dosimetry parameters such as the concentration of the photosensitizer at the tumor site, its spatial localization (intracellular or extracellular), light dose and distribution, oxygen distribution and concentration, and the heterogeneity of the inter‐ and intra‐tumoral microenvironment. Studying and characterizing these parameters, along with monitoring tumor heterogeneity pre‐ and post‐PDT, provides essential data for predicting therapeutic response and the design of subsequent therapies. In this review, we elucidate the role of ultrasound and photoacoustic imaging in improving PDT‐mediated outcomes in cancer ‐ from tracking photosensitizer uptake and vascular destruction, to measuring oxygenation dynamics and the overall evaluation of tumor responses. We also present recent advances in multi‐functional theranostic nanomaterials that can improve either ultrasound or photoacoustic imaging contrast, as well as deliver photosensitizers specifically to tumors. Given the wide availability, low cost, portability, and non‐ionizing nature of ultrasound and photoacoustic imaging, together with their capabilities of providing multi‐parametric morphological and functional information, these technologies are thusly inimitable when deployed in conjunction with PDT.</p>

biochemistry & molecular biology,biophysics
Photodynamic Therapy: A Rising Star in Pharmaceutical Applications

Eduard Preis,Udo Bakowsky

DOI: https://doi.org/10.3390/pharmaceutics16081072

IF: 6.525

2024-08-16

Pharmaceutics

Abstract:The interest in photodynamic therapy (PDT) has increased remarkably over the past years, with over 75% of all related articles published after 2010 (Figure 1) [...].
Photodynamic Therapy for Cancer: Mechanisms, Photosensitizers, Nanocarriers, and Clinical Studies.

Wanchen Zhao,Liqing Wang,Meihong Zhang,Zhiqi Liu,Chuanbin Wu,Xin Pan,Zhengwei Huang,Chao Lu,Guilan Quan

DOI: https://doi.org/10.1002/mco2.603

2024-01-01

MedComm

Abstract:Photodynamic therapy (PDT) is a temporally and spatially precisely controllable, noninvasive, and potentially highly efficient method of phototherapy. The three components of PDT primarily include photosensitizers, oxygen, and light. PDT employs specific wavelengths of light to active photosensitizers at the tumor site, generating reactive oxygen species that are fatal to tumor cells. Nevertheless, traditional photosensitizers have disadvantages such as poor water solubility, severe oxygen-dependency, and low targetability, and the light is difficult to penetrate the deep tumor tissue, which remains the toughest task in the application of PDT in the clinic. Here, we systematically summarize the development and the molecular mechanisms of photosensitizers, and the challenges of PDT in tumor management, highlighting the advantages of nanocarriers-based PDT against cancer. The development of third generation photosensitizers has opened up new horizons in PDT, and the cooperation between nanocarriers and PDT has attained satisfactory achievements. Finally, the clinical studies of PDT are discussed. Overall, we present an overview and our perspective of PDT in the field of tumor management, and we believe this work will provide a new insight into tumor-based PDT.
Photodynamic Therapy in the Treatment of Cancer—The Selection of Synthetic Photosensitizers

David Aebisher,Iga Serafin,Katarzyna Batóg-Szczęch,Klaudia Dynarowicz,Ewa Chodurek,Aleksandra Kawczyk-Krupka,Dorota Bartusik-Aebisher

DOI: https://doi.org/10.3390/ph17070932

IF: 4.6

2024-07-12

Pharmaceuticals

Abstract:Photodynamic therapy (PDT) is a promising cancer treatment method that uses photosensitizing (PS) compounds to selectively destroy tumor cells using laser light. This review discusses the main advantages of PDT, such as its low invasiveness, minimal systemic toxicity and low risk of complications. Special attention is paid to photosensitizers obtained by chemical synthesis. Three generations of photosensitizers are presented, starting with the first, based on porphyrins, through the second generation, including modified porphyrins, chlorins, 5-aminolevulinic acid (ALA) and its derivative hexyl aminolevulinate (HAL), to the third generation, which is based on the use of nanotechnology to increase the selectivity of therapy. In addition, current research trends are highlighted, including the search for new photosensitizers that can overcome the limitations of existing therapies, such as heavy-atom-free nonporphyrinoid photosensitizers, antibody–drug conjugates (ADCs) or photosensitizers with a near-infrared (NIR) absorption peak. Finally, the prospects for the development of PDTs are presented, taking into account advances in nanotechnology and biomedical engineering. The references include both older and newer works. In many cases, when writing about a given group of first- or second-generation photosensitizers, older publications are used because the properties of the compounds described therein have not changed over the years. Moreover, older articles provide information that serves as an introduction to a given group of drugs.

pharmacology & pharmacy,chemistry, medicinal
Photodynamic therapy (PDT) of cancer: from local to systemic treatment

Janusz M. Dabrowski,Luis G. Arnaut,Janusz M. Dąbrowski

DOI: https://doi.org/10.1039/c5pp00132c

2015-01-01

Abstract:Photodynamic therapy (PDT) requires a medical device, a photosensitizing drug and adequate use of both to trigger biological mechanisms that can rapidly destroy the primary tumour and provide long-lasting protection against metastasis.

chemistry, physical,biochemistry & molecular biology,biophysics
Photodynamic Therapy and Treatment for Cancer

Jian Li

2005-01-01

Abstract:In this paper,a photodynamic therapy was introduced.The photodynamic therapy is a treatment that has high specificity,minimal invasiveness and good cosmetic outcome.It is devided into two stage.First,a kind of photosensitizer is injected in vein.Then the doctor illuminates the tumer with light of a specific wavelength,causing the photosensitizer to react with cellular oxygen to produce highly toxic singlet oxygen molecules.
Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges

Zhaoyuan Liu,Zhongjian Xie,Wenting Li,Xinqiang Wu,Xiaofeng Jiang,Guanhua Li,Liangqi Cao,Dawei Zhang,Qiwen Wang,Ping Xue,Han Zhang

DOI: https://doi.org/10.1186/s12951-021-00903-7

IF: 10.2

2021-05-29

Journal of Nanobiotechnology

Abstract:Abstract Photodynamic therapy (PDT) is a non-invasive or minimally-invasive treatment which applies photosensitizers (PSs) to create reactive oxygen species (ROS) exposed to light trigger to destroy cancer cells. PDT can activate host anti-tumor immune responses but not powerful enough to kill metastatic tumors. Because of its carrier advantage, imaging, and therapeutic function together with enhanced permeability and retention (EPR) effect, nano-materials have already been used in photo-immunotherapy. Herein, photodynamic immunotherapy (PDIT) based on nanotechnology seems to be a hopeful new form of cancer therapy. In this article, we firstly summarize the recent development in photodynamic immunotherapy based on nanotechnology.

biotechnology & applied microbiology,nanoscience & nanotechnology
Photodynamic Therapy - an Update on Clinical Applications

Zheng Huang,Libo Li,Hongwei Wang,Xiuli Wang,Kaihua Yuan,Arlen Meyers,Lihao Yang,Fred W. Hetzel

DOI: https://doi.org/10.1142/s1793545809000401

2009-01-01

Abstract:Photodynamic therapy (PDT) has received increased attention since the regulatory approvals of several photosensitizers and light applicators in numerous countries and regions around the world. In recent years, much progress has been seen in basic research as well as clinical application. PDT clinical application has now extended from treating malignant diseases to nonmalignant diseases. This review article will present recent clinical data published in English journals. The data will be organized according to their clinical specialties. The new development and future direction in clinical applications of PDT for the management of both malignant and nonmalignant diseases will be discussed.
Photodynamic Therapy and Its Role in Combined Modality Anticancer Treatment

N. Patrik Brodin,Chandan Guha,Wolfgang A. Tomé

DOI: https://doi.org/10.1177/1533034614556192

2014-11-05

Abstract:Photodynamic therapy (PDT) is a relatively new modality for anticancer treatment and although the interest has increased greatly in the recent years, it is still far from clinical routine. As PDT consists of administering a nontoxic photosensitizing chemical and subsequently illuminating the tumor with visible light, the treatment is not subject to dose-limiting toxicity, which is the case for established anticancer treatments like radiation therapy or chemotherapy. This makes PDT an attractive adjuvant therapy in a combined modality treatment regimen, as PDT provides an antitumor immune response through its ability to elicit the release of damage-associated molecular patterns and tumor antigens, thus providing an increased antitumor efficacy, potentially without increasing the risk of treatment-related toxicity. There is great interest in the elicited immune response after PDT and the potential of combining PDT with other forms of treatment to provide potent antitumor vaccines. This review summarizes recent studies investigating PDT as part of combined modality treatment, hopefully providing an accessible overview of the current knowledge that may act as a basis for new ideas or systematic evaluations of already promising results.

oncology
Current Advances in Photodynamic Therapy (PDT) and the Future Potential of PDT-Combinatorial Cancer Therapies

Niuska Alvarez,Ana Sevilla

DOI: https://doi.org/10.3390/ijms25021023

IF: 5.6

2024-01-14

International Journal of Molecular Sciences

Abstract:Photodynamic therapy (PDT) is a two-stage treatment that implies the use of light energy, oxygen, and light-activated compounds (photosensitizers) to elicit cancerous and precancerous cell death after light activation (phototoxicity). The biophysical, bioengineering aspects and its combinations with other strategies are highlighted in this review, both conceptually and as they are currently applied clinically. We further explore the recent advancements of PDT with the use of nanotechnology, including quantum dots as innovative photosensitizers or energy donors as well as the combination of PDT with radiotherapy and immunotherapy as future promising cancer treatments. Finally, we emphasize the potential significance of organoids as physiologically relevant models for PDT.

biochemistry & molecular biology,chemistry, multidisciplinary
Photodynamic Therapy (PDT) in Oncology

Ángeles Juarranz,Yolanda Gilaberte,Salvador González

DOI: https://doi.org/10.3390/cancers12113341

2020-11-12

Cancers

Abstract:The issue is focused on Photodynamic Therapy (PDT), which is a minimally invasive therapeutic modality approved for treatment of several types of cancer and non-oncological disorders [...]

oncology

Photodynamic Therapy in Cancer: Principles, State of the Art, and Future Directions

Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors

Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions

Photodynamic Therapy: Current Status and Future Directions

The Current Status of Photodynamic Therapy in Cancer Treatment

Enhancing Precision in Photodynamic Therapy: Innovations in Light-Driven and Bioorthogonal Activation

The Perspective of Photodynamic Therapy in Cancer Management

Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status

Recent Studies in Photodynamic Therapy for Cancer Treatment: From Basic Research to Clinical Trials

Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer

Photodynamic Therapy: A Rising Star in Pharmaceutical Applications

Photodynamic Therapy for Cancer: Mechanisms, Photosensitizers, Nanocarriers, and Clinical Studies.

Photodynamic Therapy in the Treatment of Cancer—The Selection of Synthetic Photosensitizers

Photodynamic therapy (PDT) of cancer: from local to systemic treatment

Photodynamic Therapy and Treatment for Cancer

Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges

Photodynamic Therapy - an Update on Clinical Applications

Photodynamic Therapy and Its Role in Combined Modality Anticancer Treatment

Current Advances in Photodynamic Therapy (PDT) and the Future Potential of PDT-Combinatorial Cancer Therapies

Photodynamic Therapy (PDT) in Oncology